Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model.

Source:http://linkedlifedata.com/resource/pubmed/id/16772043

Download in:

View as

General Info

PMID
16772043